Overview
What I Offer
Strategic Program Design & Leadership
I develop and lead comprehensive public health initiatives—from situational diagnosis to program execution and evaluation—tailored to local contexts and aligned with health system goals.Diagnostics Modernization & Capacity Strengthening
Leveraging platforms like GeneXpert, I optimize lab workflows and train teams to deliver fast, accurate TB and malaria diagnostics, anchoring these program outcomes to national health strategies.Evidence-Informed Policy Engagement
Whether it’s drafting policy briefs, facilitating stakeholder dialogues, or advising on regulatory frameworks, I ensure programs influence—and are supported by—policy ecosystems.Performance Monitoring & Adaptive Learning
I embed rigorous M&E frameworks that measure real-world outcomes—like improved diagnostic accuracy—and use that data for continuous program refinement and policymaker engagement.
How I Work
Assess & Strategize
Identify gaps in diagnostics, workflows, and policy alignment—then design a comprehensive program roadmap.Implement & Integrate
Deploy diagnostic platforms (e.g., GeneXpert), streamline lab operations, and develop local expertise through training.Measure & Advocate
Track performance metrics—like diagnostic accuracy improvements—and use these insights to influence policy and resource allocation.Sustain & Scale
Build institutional capacity, strengthen governance structures, and embed quality systems to ensure long-term resilience and program reach.
| Benefit | Outcome |
|---|---|
| Measurable Impact | 20% improvement in TB diagnostic accuracy in Tanzanian hospitals |
| Rapid Diagnostics | Adoption of GeneXpert enabled faster, more precise disease detection |
| Policy-Aligned Programs | Strategy grounded in both lab performance and policy frameworks |
| Sustainable Gains | Capacity building ensures durable improvements in public health systems |
1. What does a 20% improvement in diagnostic accuracy mean?
It means your diagnostic systems are not just faster—they're significantly more precise. More accurate TB diagnoses mean proper treatment, reduced transmission, and better patient outcomes.
2. Why use GeneXpert, specifically?
GeneXpert is a game-changer: it detects TB and rifampicin resistance in under 2 hours with high sensitivity and specificity—far surpassing traditional microscopy
3. How do diagnostics tie into policy engagement?
By delivering hard data—higher diagnostic accuracy, faster treatment— we influence policymakers to allocate funding, adopt new protocols, and scale successful initiatives across systems.
4. Do you include training in your leadership approach?
Absolutely. Training lab personnel on both technical and managerial fronts ensures that improved diagnostics become routine—not just one-off wins.
5. Can this model be applied to other diseases beyond TB?
Yes. While TB example is prominent, the same leadership, diagnostics, and policy engagement framework applies to malaria, emerging pathogens, and broader health systems strengthening efforts.